This article includes a list of general references, but it lacks sufficient corresponding inline citations .(July 2022) |
Michael Stebbins | |
---|---|
Education | State University of New York, Cold Spring Harbor Laboratory (PhD) |
Known for | Proposing the creation of ARPA-H, authoring 8 executive Actions for President Obama. |
Scientific career | |
Fields | Genetics, Public Policy |
Institutions | The White House |
Michael Stebbins is an American geneticist and former Vice President of Science and Technology at the Laura and John Arnold Foundation. He previously served as Assistant Director for Biotechnology, at the White House Office of Science and Technology Policy.
He received his B.S. in biology from the State University of New York at Stony Brook, and his Ph.D. in genetics while working at Cold Spring Harbor Laboratory, where he constructed transgenic systems to control gene expression in the brains of animals for the study of long-term memory formation. That system is now used to create sterile male mosquitoes for the control of dengue fever and other mosquito borne diseases. Stebbins also created the first monoclonal antibody against luciferase, which is now sold worldwide in research kits using luciferase.
Stebbins is a former member of the National Academies of Science, Board on Research Data and Information. He serves on the Board of Directors for the Value in Cancer Care Consortium that aims to improve access, affordability, and value of cancer therapies and chairs the board for Vivli, whose mission is to "Promote, coordinate, and facilitate clinical research data sharing through the creation and implementation of a sustainable global data-sharing enterprise."
He is the former President of the SEA Action Fund, a partner organization to Scientists and Engineers for America and co-founded and 'served on the Board of Scientists and Engineers for America (SEA), an organization that focused on promoting sound science in government. He is the former Director of Biology Policy for the Federation of American Scientists (FAS), where he worked on control of biological weapons, preparedness for biological, nuclear, and chemical weapons attacks, and the responsible use of science and technology.
On November 18, 2008, Stebbins was named a member of the Obama transition in the "Executive Office of the President Team," with responsibility for the Office of Science Technology and Policy." [1]
At the White House, Stebbins was responsible for developing and driving initiatives in life sciences research, including the Administration’s efforts focused on improving veterans’ mental health, combating antibiotic resistance, increasing access to federally funded scientific research results, restoring pollinator health, and reforming the regulatory system for biotechnology products.
Dr. Stebbins served as the Vice President of Science and Technology for the Laura and John Arnold Foundation where he was responsible for opening their Washington DC office and establishing a science and technology investment portfolio for the foundation.
In April 2020, Stebbins co-wrote the proposal for the creation of a new federal agency modeled on DARPA, but focused on health. That proposal was adopted by the President Biden's campaign and became the model used to establish the Advanced Research Projects Agency for Health (ARPA-H).
Previously, Stebbins worked as a legislative fellow for U. S. Senator Harry Reid (D-NV) where he led efforts to repeal President George W. Bush's ban on the use of federal funding for research on embryonic stem cells and created a platform for addressing the challenges faced by people with disabilities.
He worked as a policy fellow for the National Human Genome Research Institute. He has also worked as a senior editor for the journal Nature Genetics, and as a science journalist for Reuters. He has written for Seed Magazine, and is a science advisor to ScienCentral, a company that produces science-related news stories for ABC and NBC television affiliates.
Stebbins is the author of the book Sex, Drugs and DNA: Science's Taboos Confronted' and was also a frequent contributor to This Week in Science, where he discussed issues relating to science and policy in his segment titled, The Weird from Washington.
The National Medal of Science is an honor bestowed by the President of the United States to individuals in science and engineering who have made important contributions to the advancement of knowledge in the fields of behavioral and social sciences, biology, chemistry, engineering, mathematics and physics. The twelve member presidential Committee on the National Medal of Science is responsible for selecting award recipients and is administered by the National Science Foundation (NSF). It is the highest science award in the United States.
Michael Smith was a British-born Canadian biochemist and businessman. He shared the 1993 Nobel Prize in Chemistry with Kary Mullis for his work in developing site-directed mutagenesis. Following a PhD in 1956 from the University of Manchester, he undertook postdoctoral research with Har Gobind Khorana at the British Columbia Research Council in Vancouver, British Columbia, Canada. Subsequently, Smith worked at the Fisheries Research Board of Canada Laboratory in Vancouver before being appointed a professor of biochemistry in the UBC Faculty of Medicine in 1966. Smith's career included roles as the founding director of the UBC Biotechnology Laboratory and the founding scientific leader of the Protein Engineering Network of Centres of Excellence (PENCE). In 1996 he was named Peter Wall Distinguished Professor of Biotechnology. Subsequently, he became the founding director of the Genome Sequencing Centre at the BC Cancer Research Centre.
Eric Steven Lander is an American mathematician and geneticist who is a professor of biology at the Massachusetts Institute of Technology (MIT), and a professor of systems biology at Harvard Medical School. Eric Lander is founding director emeritus of the Broad Institute of MIT and Harvard.
Harold Eliot Varmus is an American Nobel Prize-winning scientist. He is currently the Lewis Thomas University Professor of Medicine at Weill Cornell Medicine and a senior associate at the New York Genome Center.
The Texas A&M Institute of Biosciences and Technology (IBT), a component of Texas A&M Health, and The Texas A&M University System, is located in the world's largest medical center, the Texas Medical Center, in Houston, Texas. The institute provides a bridge between Texas A&M University System scientists and other institutions' researchers working in the Texas Medical Center and the biomedical and biotechnology research community in Houston. It emphasizes collaboration between member scientists and others working in all the fields of the biosciences and biotechnology. IBT encourages its scientists to transfer discoveries made in their laboratories to the clinic and marketplace.
The President's Council of Advisors on Science and Technology (PCAST) is a council, chartered in each administration with a broad mandate to advise the president of the United States on science and technology. The current PCAST was established by Executive Order 13226 on September 30, 2001, by George W. Bush, was re-chartered by Barack Obama's April 21, 2010, Executive Order 13539, by Donald Trump's October 22, 2019, Executive Order 13895, and by Joe Biden's February 1, 2021, Executive Order 14007.
Gilbert S. Omenn is an American medical doctor and researcher. He currently is the Harold T. Shapiro Distinguished University Professor at the University of Michigan; professor of Computational medicine & bioinformatics, Molecular medicine & genetics, Human genetics, and Public health; and the Director of the UM Center for Computational Medicine & Bioinformatics. He is the discover of Omenn syndrome, a genetic disorder that is fatal in infancy unless treated. Omenn has served as editor of the Annual Review of Public Health from 1990–1996. and as president of the American Association for the Advancement of Science (AAAS). He has published more than 600 peer-reviewed papers and reviews and is the author or editor of 18 books.
Frances Hamilton Arnold is an American chemical engineer and Nobel Laureate. She is the Linus Pauling Professor of Chemical Engineering, Bioengineering and Biochemistry at the California Institute of Technology (Caltech). In 2018, she was awarded the Nobel Prize in Chemistry for pioneering the use of directed evolution to engineer enzymes.
Sir John Irving Bell is a Canadian-British immunologist and geneticist. From 2006 to 2011, he was President of the United Kingdom's Academy of Medical Sciences, and since 2002 he has held the Regius Chair of Medicine at the University of Oxford. He was since 2006 Chairman of the Office for Strategic Coordination of Health Research (OSCHR) but in 2020 became a normal member. Bell was selected to the Vaccine Taskforce sometime before 1 July 2020. Bell is also on the board of directors of the SOE quango Genomics England.
Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014 to 2020. In March 2024 she was elected as a board member of OpenAI. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.
Aneesh Paul Chopra is an American executive who served as the first Chief Technology Officer of the United States. He was appointed in 2009 by President Barack Obama and was at the White House through 2012. Chopra previously served as Virginia's Secretary of Technology under Governor Tim Kaine. Chopra was a candidate in 2013 for the Democratic nomination for Lieutenant Governor of Virginia. He is the author of Innovative State: How New Technologies Can Transform Government (2014) and co-founder and president of CareJourney. In 2015 he joined Albright Stonebridge Group as a senior advisor.
Sheldon Krimsky was a professor of Urban and Environmental Policy and Planning at Tufts University, and adjunct professor in the Department of Family Medicine and Community Health at Tufts University School of Medicine. He was a fellow of the Hastings Center, an independent bioethics research institution.
Francis Sellers Collins is an American physician-scientist who discovered the genes associated with a number of diseases and led the Human Genome Project. He served as director of the National Institutes of Health (NIH) in Bethesda, Maryland, from 17 August 2009 to 19 December 2021, serving under three presidents.
Paolo Boffetta is an Italian epidemiologist. He is doing research on cancer and other chronic diseases, where he contributed to the understanding of the role of occupation, environment, alcohol, smoking and nutrition in disease development. In 2013, his candidacy for the position of Director of France's national center for research in epidemiology and public health was withdrawn as a result of his extensive consulting work for industry in lawsuits involving asbestos.
Alondra Nelson is an American academic, policy advisor, non-profit administrator, and writer. She is the Harold F. Linder chair and professor in the School of Social Science at the Institute for Advanced Study, an independent research center in Princeton, New Jersey. Since March 2023, she has been a distinguished senior fellow at the Center for American Progress. In October 2023, she was nominated by the Biden-Harris Administration and appointed by United Nations Secretary-General António Guterres to the UN High-Level Advisory Body on Artificial Intelligence.
Claire Nader is an American social scientist and a sister of Ralph, Laura, and Shafeek Nader.
Manchanahalli Rangaswamy Satyanarayana Rao was an Indian scientist. He was awarded the fourth-highest civilian award, the Padma Shri, for Science and Engineering in 2010. From 2003 to 2013 he was president of Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) in Bangalore, India.
Geoffrey S. F. Ling is a medical doctor who retired from the United States Army as a colonel and was the CEO of On Demand Pharmaceuticals. He served as the founding director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office from 2014 until 2016. He was considered to be the "US Army's premier subject matter expert on traumatic brain injury (TBI)", and was for years the only neuro-intensive care specialist in the US military.
Kei Koizumi is an American policy advisor serving as Principal Deputy Director for Policy for the Office of Science and Technology Policy. He previously served as a senior advisor on science policy for the American Association for the Advancement of Science after serving as a senior advisor to the National Science and Technology Council under President Obama.
The Advanced Research Projects Agency for Health (ARPA-H) is an agency within the Department of Health and Human Services. Its mission is to "make pivotal investments in break-through technologies and broadly applicable platforms, capabilities, resources, and solutions that have the potential to transform important areas of medicine and health for the benefit of all patients and that cannot readily be accomplished through traditional research or commercial activity."